NIR Diagnostics

NIR Diagnostics Inc. was a Canadian medical technology company specializing in the development of non-invasive diagnostic devices using near-infrared (NIR) spectroscopy. The company's primary focus was on creating portable, point-of-care tools for monitoring various physiological parameters and blood analytes, such as glucose and hemoglobin levels, without the need for needles or laboratory processing. Their flagship product, the NIR-1, was designed to provide rapid results for chronic disease management in both clinical and home settings. In 2010, the company was acquired by Fio Corporation, a global healthcare technology firm. Fio integrated NIR's spectroscopic capabilities into its own mobile health platform to enhance diagnostic accuracy for infectious diseases in decentralized healthcare environments.